Sun Pharmaceutical P/E Ratio

SUNPHARMA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
37.86
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 37.86
Current Price ₹1718.00
EPS (TTM) ₹45.60
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 28.41
Historical Range 22.25 - 41.54
Percentile 83.3%

Sector Context

Sector Average 47.56
Sector Median 25.5
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹45.50
Sept 2025 ₹13.00
Mar 2025 ₹9.00

Key P/E Ratio Insights for Sun Pharmaceutical

  • Stock appears overvalued with PE of 37.86, suggesting caution for new investments
  • Current PE is 33.3% above historical average
  • Trading at discount to sector average PE of 47.56

P/E Ratio Historical Trend for Sun Pharmaceutical

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 41.54 45.5 ₹1889.95 NSE High
2024 26.42 47.7 ₹1260.25 NSE High
2023 26.87 37.1 ₹997.00 NSE High
2021 22.25 26.8 ₹596.25 NSE Moderate
2019 26.01 16.67 ₹433.55 NSE High
2016 27.37 29.8 ₹815.55 NSE High

Sector P/E Ratio Comparison

Comparing Sun Pharmaceutical with other companies in Healthcare sector
Sector Average
47.56
Sector Median
25.5
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low